Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report 2021 - 2028

 Clinical Oncology Next Generation Sequencing Industry Overview

The global clinical oncology next generation sequencing market size was valued at USD 297.9 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 14.70% from 2021 to 2028. The technology facilitates time- and cost-effective sequencing of tumor DNA, which, in turn, has brought about a “genomic era” of cancer treatment as well as research. Next generation sequencing (NGS) has brought noteworthy developments in personalized medicine for oncology. This is because the technology enables the identification of resistance mechanisms, germline, and somatic mutations, and allows quantification of mutational burden of cancers. These factors are anticipated to aid in increasing the clinical utility of NGS in precision oncology care.

Rise in clinical applications of next-generation sequencing in precision oncology has driven the efforts of the key companies to develop novel platforms that can be used for genomic assays. For instance, in February 2021, Congenica collaborated with Gabriel Precision Oncology Ltd. to manufacture an automatic clinical oncology interpretation software platform.

Gather more insights about the market drivers, restrains and growth of the Global Clinical Oncology Next Generation Sequencing market

This product will facilitate NGS-based molecular diagnostics of tumors in routine clinical practice. In January 2021, 4baseCare; a precision oncology start-up collaborated with Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), India to develop ClinOme - an AI-driven clinical interpretation platform.

This platform analyses NGS raw data, which is used by clinicians to categorize and interpret genomic alterations along with experimental and approved therapies for each resistant and responsive genotype-drug combination. This further increases the use of NGS data analysis platforms for personalized oncology treatment.


Browse through Grand View Research's Biotechnology Industry Research Reports.

  • Microarray Market - The global microarray market size was valued at USD 3.90 billion in 2018 and is anticipated to grow at a CAGR of 8.7% during the forecast period. Microarrays have a wide range of applications and have found increasing usage in basic molecular biology, toxicological response profiling, pharmaceutical target screening, and biomarker identification. The ability of microarrays to facilitate the analysis of thousands of genes at the same time has resulted in the success of this technology in the past few years.

  • Immunoprecipitation Market - The global immunoprecipitation market size was valued at USD 605.0 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 5.3% from 2019 to 2026. Growing number of research activities in the life science sector is driving the market. In addition, technological advancements in immunoprecipitation technique is fostering market growth.

 

Clinical Oncology Next Generation Sequencing Market Segmentation

Grand View Research has segmented the global clinical oncology next generation sequencing market on the basis of technology, workflow, application, end-use, and region:

Clinical Oncology NGS Technology Outlook (Revenue, USD Million, 2017 - 2028)

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing Centrifuges

 

Clinical Oncology NGS Workflow Outlook (Revenue, USD Million, 2017 - 2028)

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

 

Clinical Oncology NGS Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Screening
  • Companion Diagnostics
  • Other Diagnostics

 

Clinical Oncology NGS End-use Outlook (Revenue, USD Million, 2017 - 2028)

  • Hospitals
  • Clinics
  • Laboratories

 

Clinical Oncology NGS Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • May 2020: Burning Rock Biotech Limited; a China-based cancer test provider, partnered with Illumina to promote the standardization and development of NGS-based cancer therapy selection within China. The company also signed an agreement with Myriad Genetics, Inc. 

 

Key Companies profiled:

Some prominent players in the global Clinical Oncology Next Generation Sequencing market include

  • Illumina, Inc.
  • Thermo Fisher Scientific
  • Hoffmann-La Roche Ltd.
  • Agilent Technologies
  • Myriad Genetics
  • Beijing Genomics Institute (BGI)
  • Perkin Elmer
  • Foundation Medicine
  • Pacific Bioscience
  • Oxford Nanopore Technologies Ltd.
  • Paradigm Diagnostics
  • Caris Life Sciences
  • Partek, Inc.
  • Eurofins Scientific S.E.
  • Qiagen N.V.

 

Order a free sample PDF of the Clinical Oncology Next Generation Sequencing Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more